The Calculated Delay: Active Surveillance for Localized Prostate Cancer
In urologic oncology, the cure is often more immediately destructive than the disease. Subjecting a 70-year-old man to a radical prostatectomy for a microscopic, slow-growing tumor guarantees impotence and incontinence, while the cancer itself might never have threatened his life. Active Surveillance for Localized Prostate Cancer: A New Paradigm is the fiercely debated, highly statistical master text of intentional inaction. This volume provides the exact clinical and mathematical blueprints required to safely monitor a lethal disease without firing a single surgical or radiological shot.
Mastering the Gleason Score Threshold
The core philosophy of this text is pathological risk stratification. The authors aggressively detail the mechanics of the biopsy. It dictates exactly how a urologist must interpret a Gleason 6 tumor, using complex PSA kinetics and multiparametric MRI to scientifically prove to a terrified patient that the cancer inside them is so lazy it can be completely ignored, safely delaying devastating treatment for years or even decades.
Navigating the Psychological Burden
The book provides a masterclass in managing patient anxiety. It dictates the exact clinical pathways for treating the fear of cancer rather than the cancer itself. It rigorously explores the psychological toll of knowing you have a malignant tumor growing inside your body and actively choosing not to cut it out, detailing the specific counseling required to prevent the patient from demanding a medically unnecessary, life-altering surgery out of sheer panic.
Frequently Asked Questions (FAQs)
Is this a book about how to perform a robotic prostatectomy?
Absolutely not. It is a strictly specialized *urologic oncology, clinical decision-making, and disease management textbook* focused entirely on the scientific justification for *avoiding* surgery.
Who is the primary audience?
It is the absolute, mandatory clinical guide for Urologists, Medical Oncologists, Radiation Oncologists, and Primary Care Physicians.
